Clinical Trial Update: An Open-Label, Single- and Multi-Dose Pharmacokinetic (PK) Study of Oral Diltiazem and Topical Diltiazem Hydrochloride [Phase 1]

View source ↗

Summary

This is an open-label Phase 1 pharmacokinetic study of oral and topical diltiazem hydrochloride in adults with anal fissures, with the status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Fissure

Drugs mentioned

• Diltiazem (oral) (diltiazem)
• Diltiazem hydrochloride (topical) (diltiazem hydrochloride)

Snippet

Sponsor: Ventrus Biosciences, Inc | Conditions: Adult Subjects With Anal Fissures. | Phase 1 | Status: UNKNOWN